Reply to K.A. Olaussen et al
Publication
, Journal Article
Wang, LE; Amos, CI; Spitz, MR; Wei, Q
Published in: Journal of Clinical Oncology
May 1, 2012
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 1, 2012
Volume
30
Issue
13
Start / End Page
1568 / 1569
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, L. E., Amos, C. I., Spitz, M. R., & Wei, Q. (2012). Reply to K.A. Olaussen et al. Journal of Clinical Oncology, 30(13), 1568–1569. https://doi.org/10.1200/JCO.2011.41.1728
Wang, L. E., C. I. Amos, M. R. Spitz, and Q. Wei. “Reply to K.A. Olaussen et al.” Journal of Clinical Oncology 30, no. 13 (May 1, 2012): 1568–69. https://doi.org/10.1200/JCO.2011.41.1728.
Wang LE, Amos CI, Spitz MR, Wei Q. Reply to K.A. Olaussen et al. Journal of Clinical Oncology. 2012 May 1;30(13):1568–9.
Wang, L. E., et al. “Reply to K.A. Olaussen et al.” Journal of Clinical Oncology, vol. 30, no. 13, May 2012, pp. 1568–69. Scopus, doi:10.1200/JCO.2011.41.1728.
Wang LE, Amos CI, Spitz MR, Wei Q. Reply to K.A. Olaussen et al. Journal of Clinical Oncology. 2012 May 1;30(13):1568–1569.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 1, 2012
Volume
30
Issue
13
Start / End Page
1568 / 1569
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences